They employ diverse sensing mechanisms such as optical (e.g., SPR), electrochemical, and mass-based (e.g., QCM) biosensors, enabling accurate measurement of cancer indicators such as prostate-specific antigen (PSA) or facilitating continuous monitoring of breast cancer biomarkers. The gene discussed is PROS1; the disease is cancer.